Wingstop (WING): Assessing Valuation After Recent 16% Share Price Pullback

Wingstop (WING) shares have come under pressure lately, falling 16% in just the past month. Investors are watching closely to see if this trend signals a change in appetite for the fast-casual chicken chain.

See our latest analysis for Wingstop.

Wingstop’s recent 5.7% one-month share price slide comes after a year marked by choppy trading, which has overshadowed earlier successes. Even with the stock pulling back this year, long-term investors have seen a total shareholder return topping 112% over three years. While near-term momentum is clearly fading, the bigger picture is one of impressive long-term growth.

If the current shift in sentiment has you curious about what else is delivering big moves, now is a perfect moment to broaden your search and discover fast growing stocks with high insider ownership

With shares sliding and valuation metrics in focus, the question for investors is clear: is Wingstop undervalued after its recent pullback, or is the market already pricing in all the growth ahead?

Advertisement

Most Popular Narrative: 35.5% Undervalued

Compared to Wingstop’s latest close at $246.27, the narrative’s fair value estimate of $381.83 stands out, suggesting a valuation well above current market levels and shifting the conversation to what could be driving such optimism.

The rapid roll-out and full system implementation of the Wingstop Smart Kitchen platform is significantly improving operational efficiency, order throughput, guest satisfaction, speed of service, and consistency. This is expected to drive higher same-store sales, increased delivery frequency, and better net margins as restaurants ramp to the new model.

Read the complete narrative.

Curious what bold growth assumptions power this valuation? Behind the headline is a deep belief in expansion and digital transformation, but the real secret is in analyst forecasts. Ready to unravel the numbers and see what sets this narrative apart from the market buzz?

Result: Fair Value of $381.83 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent demand softness and slowing menu innovation could quickly dampen Wingstop’s growth story if these headwinds intensify in coming quarters.

Find out about the key risks to this Wingstop narrative.

Another View: Can Market Multiples Tell a Different Story?

While the fair value narrative points to Wingstop as meaningfully undervalued, a look at its price-to-earnings ratio tells a different tale. At 40.1x, its valuation is far higher than the US Hospitality industry average of 23.8x and even above the fair ratio of 21.1x. This kind of premium may signal investor optimism, or it could expose the stock to valuation risk if growth stalls. Is the market right to price in so much future success, or could a reversion to the fair ratio mean a painful reset ahead?

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:WING PE Ratio as at Oct 2025
NasdaqGS:WING PE Ratio as at Oct 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Wingstop for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Wingstop Narrative

If you see the numbers differently or want to chart your own path, it takes just a few minutes to craft a unique perspective. Do it your way.

A great starting point for your Wingstop research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Give your portfolio an edge and spot untapped opportunities before the crowd by using these hand-curated stock lists. Don’t let the next big winner pass you by.

  • Unlock the potential of future tech by checking out these 26 quantum computing stocks. This list highlights innovation in quantum computing and explores new possibilities in data and security.
  • Capitalize on life-changing healthcare breakthroughs and see which companies stand out among these 33 healthcare AI stocks. These firms are harnessing artificial intelligence to advance medical science and patient care.
  • Benefit from steady income streams with these 20 dividend stocks with yields > 3%, which offers high yields and strong fundamentals for investors focused on sustainable returns.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Wingstop might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:WING

Wingstop

Wingstop Inc., together with its subsidiaries, franchises and operates restaurants under the Wingstop brand in United States, Australia, Bahrain, Kuwait, Puerto Rico, Saudi Arabia, and The Netherlands.

Low risk and slightly overvalued.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7719.9% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9217.2% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1907.4% undervalued
24 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.9% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
85 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
193 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0